LAA Performs Pioneering Roadside Occlusive Balloon Surgery
|
By HospiMedica International staff writers Posted on 30 Jun 2014 |

Image: Dr. Gareth Davies, medical director of the LAA (Photo courtesy of London Air Ambulance).
The London Air Ambulance (LAA; United Kingdom) has performed the world’s first roadside resuscitative endovascular balloon occlusion of the aorta (REBOA) to control internal bleeding.
REBOA is a proactive circulatory support method for hypotensive patients at risk of cardiovascular collapse. It works by controlling or preventing further blood loss via a balloon fed into the inferior part of the aorta and then inflated, temporarily cutting off blood supply to damaged blood vessels. Occlusion of the thoracic aorta can provide inflow control in patients with exsanguinating abdominal trauma, whereas occlusion of the infrarenal aorta can control pelvic hemorrhage.
The pioneering technique could prevent trauma patients bleeding to death from severe pelvic hemorrhage, an injury most commonly associated with cycling incidents and falls from height. The technique was developed over two year in conjunction with the Royal London Hospital (RLH; United Kingdom), the LAA’s home base, which continues treatment of the patient with further hospital interventions.
“We believe the use of REBOA can lead to a reduction in the number of patients who quite simply bleed to death before they have the chance to get to hospital where there are highly developed systems for stabilizing and preventing blood loss,” said Gareth Davies, MD, medical director of the LAA. “Our aim is to provide our patients with the world’s most innovative and effective pre-hospital care. Being able to effectively manage blood loss at the scene is a significant advancement in pre-hospital medicine.”
“We have to stop people bleeding to death—it's one of the world's biggest killers. Over 2.5 million people bleed to death from their injuries each year around the world,” added Prof. Karim Brohi, consultant vascular and trauma surgeon at RLH. “While it sounds relatively simple it is an extremely difficult technology to deliver in the emergency department in hospital, never mind at the roadside. We are excited about the potential for REBOA to reduce death and suffering after trauma and will continue to evaluate and develop the technology into the future.”
LAA is a registered charity that functions as a mobile emergency department in life-threatening, time-critical situations, and carries a senior doctor (in addition to a paramedic) at all times on a helicopter, thus reducing the death rate in severe trauma by 30%–40%. Based in RLH, the helicopter can reach any patient inside the M25 London orbital road within 15 minutes. Missions commonly involve serious road traffic collisions, falls from height, stabbings and shootings, industrial accidents, and incidents on the rail network. The team can provide advanced life-saving medical interventions, including open heart surgery, blood transfusion, and anesthesia at the scene.
Related Links:
London Air Ambulance
Royal London Hospital
REBOA is a proactive circulatory support method for hypotensive patients at risk of cardiovascular collapse. It works by controlling or preventing further blood loss via a balloon fed into the inferior part of the aorta and then inflated, temporarily cutting off blood supply to damaged blood vessels. Occlusion of the thoracic aorta can provide inflow control in patients with exsanguinating abdominal trauma, whereas occlusion of the infrarenal aorta can control pelvic hemorrhage.
The pioneering technique could prevent trauma patients bleeding to death from severe pelvic hemorrhage, an injury most commonly associated with cycling incidents and falls from height. The technique was developed over two year in conjunction with the Royal London Hospital (RLH; United Kingdom), the LAA’s home base, which continues treatment of the patient with further hospital interventions.
“We believe the use of REBOA can lead to a reduction in the number of patients who quite simply bleed to death before they have the chance to get to hospital where there are highly developed systems for stabilizing and preventing blood loss,” said Gareth Davies, MD, medical director of the LAA. “Our aim is to provide our patients with the world’s most innovative and effective pre-hospital care. Being able to effectively manage blood loss at the scene is a significant advancement in pre-hospital medicine.”
“We have to stop people bleeding to death—it's one of the world's biggest killers. Over 2.5 million people bleed to death from their injuries each year around the world,” added Prof. Karim Brohi, consultant vascular and trauma surgeon at RLH. “While it sounds relatively simple it is an extremely difficult technology to deliver in the emergency department in hospital, never mind at the roadside. We are excited about the potential for REBOA to reduce death and suffering after trauma and will continue to evaluate and develop the technology into the future.”
LAA is a registered charity that functions as a mobile emergency department in life-threatening, time-critical situations, and carries a senior doctor (in addition to a paramedic) at all times on a helicopter, thus reducing the death rate in severe trauma by 30%–40%. Based in RLH, the helicopter can reach any patient inside the M25 London orbital road within 15 minutes. Missions commonly involve serious road traffic collisions, falls from height, stabbings and shootings, industrial accidents, and incidents on the rail network. The team can provide advanced life-saving medical interventions, including open heart surgery, blood transfusion, and anesthesia at the scene.
Related Links:
London Air Ambulance
Royal London Hospital
Latest Hospital News News
- Nurse Tracking System Improves Hospital Workflow
- New Children’s Hospital Transforms California Healthcare
- Noisy Hospitals Face Threat of Decreased Federal Compensation
- Orthopedics Centre of Excellence Planned for Guy’s Hospital
- Research Suggests Avoidance of Low-Value Surgical Procedures
- U.S. Federal Readmission Fines Linked to Higher Mortality
- Columbia China to Build New Hospital in Jiaxing
- Dubai Debuts Second Robotic Pharmacy Service
- Seattle Hospital Network Shifts Away from Overlapping Surgeries
- ACC to Launch Valvular Heart Disease Program in China
- Mortality Rates Lower at Major Teaching Hospitals
- South Australia to Inaugurate Upscale Hospital
- Raffles to Launch Second Hospital Project in China
- Research Center Tackles Antimicrobial Drugs Challenge
- Miami Cardiac & Vascular Institute Completes Expansion Project
- Hospital Antibiotic Policies Improve Prescription Practices
Channels
Artificial Intelligence
view channel
AI Tool Improves Hospital Discharge Summaries to Support Follow-Up Care
Discharge summaries guide care after hospitalization but can be difficult to prepare after long or complex stays. Clinicians must condense treatment, medications, follow-up, and unresolved issues into... Read more
AI Tool Predicts Hypertensive Crisis Up to 72 Hours Ahead
A hypertensive crisis is a rapid and severe rise in blood pressure above 180/120 mm Hg accompanied by acute end-organ damage. It can lead to stroke, heart attack, kidney injury, aortic dissection, or pulmonary... Read moreCritical Care
view channel
Ultrasound Implant Could Help Monitor Spinal Cord Recovery After Surgery
Spinal cord injury can lead to secondary complications when changes near the injured tissue are difficult to monitor after surgery. During early recovery, patients may be immobile, limiting repeated imaging... Read more
Paper-Based Patch Integrates Sweat Sensors and Drug-Delivery Microneedles
Wearable health-monitoring patches can support personalized care, but many conventional substrates limit airflow during extended use. Poor breathability can trap sweat and cause skin discomfort.... Read more
Circuit-Free Smart Patch Uses Smartphone Camera to Monitor Pulse and Vessel Stiffness
Routine cardiovascular monitoring often relies on electronic sensors, cables, or specialized equipment, which can limit its use beyond hospitals, ambulances, general practice clinics, and emergency rooms.... Read moreSurgical Techniques
view channel
Dual-Technique Approach Improves Stent Expansion in Calcified Coronary Lesions
Calcified coronary nodules are hard, irregular calcium deposits that protrude into coronary arteries and can complicate percutaneous coronary intervention by preventing full stent expansion.... Read more
FDA Approves First Transcatheter Device for Paravalvular Leak Closure
Paravalvular leak is a backflow of blood around a surgical heart valve that can follow valve replacement, causing heart failure symptoms or hemolysis. These leaks occur in 7%–17% of mitral valve replacements... Read morePatient Care
view channel
Video-Based Support Helps Older Adults Clarify Kidney Disease Treatment Preferences
Advanced chronic kidney disease (CKD) involves progressive loss of kidney function that can lead to kidney failure and difficult treatment decisions. For older adults, these decisions may include choosing... Read more
Expert Review Outlines Diagnosis and Treatment of Recurrent Catheter Infections
Patients who rely on long-term intravenous catheters for chemotherapy, hemodialysis, intravenous nutrition, and other essential therapies remain at risk of catheter-related bloodstream infections.... Read moreMedical Imaging
view channel
Targeted ImmunoPET Scan Detects Multiple Myeloma Missed by Standard PET/CT
Multiple myeloma is a blood cancer that develops in the bone marrow and can affect multiple sites throughout the body. Standard imaging and blood tests may miss areas of active disease, potentially complicating... Read more
Researchers Develop AI Tool to Reconstruct Missing Brain Connectivity Data
Diffusion MRI helps map nerve fiber pathways in the brain, but some scans lose signal in regions that are important for understanding connectivity. These gaps can affect areas such as the brainstem and... Read more
Cardiac MRI AI Tool Improves Mortality Risk Prediction
Ejection fraction is a key measure of how effectively the heart pumps blood and is widely used to guide treatment decisions in patients with known or suspected heart disease. These measurements can influence... Read more
Imaging Biomarker Links Breast Tumor Heterogeneity to Targeted Therapy Response
Breast cancer patients can respond differently to targeted therapy, even when their tumors appear similar on conventional imaging. This variability can expose some patients to treatments that provide limited... Read moreHealth IT
view channel
Clinical Decision Support Tool Automates CKD Risk Assessment in Primary Care
Chronic kidney disease (CKD) requires timely diagnosis, risk assessment, and coordinated treatment in primary care. Delayed recognition can affect decisions about testing, blood pressure control, cardiovascular... Read more
EHR Alerts Support Dosing, Sedation, and Shock Recognition in Cardiac Care
Electronic health record alerts can add to clinician workload when they are poorly targeted. In critical cardiac care, however, delayed decisions can affect treatment timing, sedation exposure, and escalation... Read morePoint of Care
view channel
New Breath Condensate Testing Approach Enhances Reliability for COPD Monitoring
Chronic obstructive pulmonary disease (COPD) is a progressive lung condition that can increasingly impair breathing over time. Diagnosis and monitoring may be burdensome because patients often require... Read more
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read moreBusiness
view channel
Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal
Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Stryker Enters Soft-Tissue Robotics Through Strategic Alliance With CMR Surgical
Stryker (Portage, MI, USA) and CMR Surgical (Cambridge, UK) have announced a strategic alliance centered on the Versius Surgical Robotic portfolio. The agreement includes an approximately USD 400 million... Read more







